|
1.
|
2013/02
|
|
Effects of DNA methyltransferase inhibitors (DNMTIs) on MDS-derived
cell lines
|
|
2.
|
2012/06
|
|
Approach to new therapeutics: Investigation by the use of MDS-derived cell lines.Curr Pharm Design
|
|
3.
|
2011/01
|
|
The impact of serum soluble interleukin-2 receptor levels on the diagnosis of malignant lymphoma.
|
|
4.
|
2010/09
|
|
Ph clone recurrence after imatinib discontinuation for chronic myelogenous leukemia patients who had complete molecular remission.
|
|
5.
|
2010/04
|
|
Lenalidomide induces cell death in an MDS-derived cell line with deletion of chromosome 5q by inhibition of cytokinesis.
|
|
6.
|
2012/03
|
|
Rab27b regulates c-kit expression by controling the secretion of stem cell factor.
|
|
7.
|
2008/09
|
|
Validation of the revised 2008 WHO diagnostic criteria in 75 suspected cases of myeloproliferative neoplasm.
|
|
8.
|
2008/03
|
|
DNA ploidy and cell cycle analyses in the bone marrow cells of patients with megaloblastic anemia using laser scanning cytometry.
|
|
9.
|
2006/11
|
|
TRAIL expression up-regulated by interferon-gamma via phosphrylation of STAT1 induces myeloma cell death
|
|
10.
|
2006/05
|
|
The mechanisms of vitamin K2-induced apoptosis of myeloma cells.
|
|
11.
|
2006/05
|
|
Effects of peripheral cannabimoid receptor ligands on motility and polarization in neutrophil-like HL60 cells and human neutrophils
|
|
12.
|
2004/11
|
|
Expression of protein gene product 9.5 (PGP9.5)/ubiquitin-C-terminal hydrolase 1 (UCHL-1) in human myeloma cells.
|
|
13.
|
2004/07
|
|
Multiple Myeloma Complicated by Autoimmune Hemolytic Anemia.
|
|
14.
|
2004/05
|
|
Effects of an HMG-CoA reductase inhibitor, simvastatin, on human myeloma cells.
|
|
15.
|
2003/08
|
|
Expression of HER family receptors and effects of anti-HER2-antibody on human myeloma cell lines.
|
|
16.
|
2003/09
|
|
IL-6 is a key factor in growth inhibition of human myeloma cells induced by pravastatin, an HMG-CoA reductase inhibitor.
|
|
17.
|
2003/12
|
|
MLL/AF-1p Fusion in Therapy-Related Early Pre-B Acute Lymphoblastic Leukemia with a t(1;11)(p32;q23) Translocation Developing in the Relapse Phase of Acute Promyelocytic Leukemia.
|
|
18.
|
2025/03/25
|
|
Response to Panic Values at Kawasaki Medical School Hospital
|
|
19.
|
2018/08
|
|
An MDS-derived cell line and a series of its sublines serve as an in vitro model for the leukemic evolution of MDS.
|
|
20.
|
2018/06
|
|
Utility of a Fluorescence Microscopy Imaging System for Analyzing the DNA Ploidy of Pathological Megakaryocytes Including 5q- Syndrome
|
|
21.
|
2016/09
|
|
Withaferin A suppresses the growth of myelodysplasia and leukemia cell lines by inhibiting cell cycle progression.
|
|
22.
|
2016/07
|
|
Low neutrophil alkaline phosphatase score is a new aspect of calreticulin-mutated myeloproliferative neoplasms
|
|
23.
|
2015/11
|
|
Five-aza-2'-deoxycytidine-induced hypomethylation of cholesterol 25-hydroxylase gene is responsible for cell death of myelodysplasia/leukemia cells.
|
|
24.
|
2015/10
|
|
Analysis of heredirary elliptocytosis with decreased binding of eosin-5-maleimide to red blood cells
|
|
25.
|
2015/05
|
|
Rigosertib induces cell death of a myelodysplastic syndrome-derived cell line by DNA damage-induced G2/M arrest.
|
|
26.
|
2003/02
|
|
Expression of angiogenic factors including VEGFs and the effects of hypoxia and thalidomide on human myeloma cells.
|
|
27.
|
2003
|
|
Effects of All-trans retinoic acid (ATRA) on human myeloma cells.
|
|
Display 5 items
|
|
Display all(27)
|
